INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 191 filers reported holding INOVIO PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.85 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $22 | -12.0% | 57 | 0.0% | 0.00% | – |
Q2 2023 | $25 | -46.8% | 57 | 0.0% | 0.00% | – |
Q1 2023 | $47 | -80.8% | 57 | -63.7% | 0.00% | – |
Q4 2022 | $245 | – | 157 | 0.0% | 0.00% | – |
Q3 2022 | $0 | – | 157 | -24.2% | 0.00% | – |
Q2 2022 | $0 | -100.0% | 207 | +3.5% | 0.00% | – |
Q1 2022 | $1,000 | 0.0% | 200 | 0.0% | 0.00% | – |
Q4 2021 | $1,000 | -75.0% | 200 | -60.0% | 0.00% | – |
Q3 2021 | $4,000 | -20.0% | 500 | 0.0% | 0.00% | – |
Q2 2021 | $5,000 | -100.0% | 500 | -91.1% | 0.00% | – |
Q1 2021 | $52,340,000 | +747614.3% | 5,640 | +650.0% | 0.00% | – |
Q4 2020 | $7,000 | -63.2% | 752 | -53.0% | 0.00% | – |
Q3 2020 | $19,000 | +26.7% | 1,600 | +190.9% | 0.00% | – |
Q2 2020 | $15,000 | +1400.0% | 550 | +266.7% | 0.00% | – |
Q1 2020 | $1,000 | -93.3% | 150 | -96.8% | 0.00% | – |
Q4 2019 | $15,000 | +66.7% | 4,650 | 0.0% | 0.00% | – |
Q3 2019 | $9,000 | -30.8% | 4,650 | 0.0% | 0.00% | – |
Q2 2019 | $13,000 | -58.1% | 4,650 | -17.0% | 0.00% | -100.0% |
Q3 2018 | $31,000 | +29.2% | 5,600 | -8.2% | 0.00% | 0.0% |
Q2 2018 | $24,000 | +33.3% | 6,099 | +52.5% | 0.00% | 0.0% |
Q1 2018 | $18,000 | +12.5% | 3,999 | 0.0% | 0.00% | 0.0% |
Q4 2017 | $16,000 | -30.4% | 3,999 | +8.1% | 0.00% | -50.0% |
Q3 2017 | $23,000 | -20.7% | 3,699 | 0.0% | 0.00% | -33.3% |
Q2 2017 | $29,000 | +52.6% | 3,699 | +23.3% | 0.00% | 0.0% |
Q1 2017 | $19,000 | -5.0% | 3,000 | 0.0% | 0.00% | -66.7% |
Q4 2016 | $20,000 | – | 3,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|